Skip to content
Screener

Perrigo Company PRGO Digestive Health — Net Sales

Other product segments

Oral Care
$354.4M-5.4%
Upper Respiratory
$178.4M-1.6%
Skin Health
$161.8M—
Healthy Lifestyle
$157.8M+2.0%
Pain & Sleep
$124.6M—
Women's Health
$64.8M+3.3%

Similar metrics at other companies

Nature's Sunshine Products logo
NATRDigestive — Net Sales
$28.71M+2.9%
Nature's Sunshine Products logo
NATRGeneral health — Net Sales
$48.9M+3.2%
Oil-Dri Corporation of America logo
ODCAnimal Health & Nutrition — Net Sales
$6.36M+10.2%
International Flavors & Fragrances logo
IFFHealth & Biosciences — Net Sales
$595M+10.2%
Kenvue logo
KVUEEssential Health — Net Sales
$1.25B+2.3%
The Clorox Company logo
CLXHealth and Wellness — Net Sales
$860M+16.1%

Other financials

Income statement

See full
Revenue$1.0B-3.2%
Gross profit$313.9M-13.5%
Operating income$23.5M-48.2%
Net income$74.5M+987%
EPS (diluted)$0.53+983%

Balance sheet

See full
Cash & equivalents$399.7M-12.0%
Total debt$3.5B-10.3%
Total equity$2.5B-43.7%
Total assets$7.6B-24.6%

Cash flow

See full
Operating cash flow-$113.6M-76.1%
CapEx$14.3M-25.5%
Free cash flow-$127.4M-41.6%

Valuation

See full
Market cap$1.74B-46.4%
Enterprise value$4.82B-27.7%
P/S0.4×-0.3×

Profitability

See full
Gross margin33.3%-2.5pp
Operating margin-37.7%-44.3pp
Net margin-41.9%-43.9pp
FCF margin4.2%-2.0pp

Returns & leverage

See full
Return on equity-49.6%-51.6pp
Debt / equity1.4×+0.5×
Current ratio2.3×0.0×

Where this comes from

Reported directly by Perrigo Company in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Perrigo Company’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 1:44 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001585364-26-000145
Line itemThree Months Ended / June 27, 2026Three Months Ended / June 28, 2025Six Months Ended / June 27, 2026Six Months Ended / June 28, 2025
Self Care
Upper Respiratory$178.4$181.3$375.7$396.0
Digestive Health115.7119.8212.4232.6
Healthy Lifestyle157.8154.7300.6311.7
Pain & Sleep124.6142.8231.2272.5
Total Self Care$576.6$598.6$1,119.9$1,212.8
Specialty Care
Skin Health$161.8$170.3$313.7$319.9

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

FAQ

What is Perrigo Company's digestive health — net sales?
Perrigo Company (PRGO) reported digestive health — net sales of $115.7M in Q2 2026.
How has Perrigo Company's digestive health — net sales changed year-over-year?
Perrigo Company's digestive health — net sales decreased by 3.4% year-over-year, from $119.8M to $115.7M.
What is the long-term trend for Perrigo Company's digestive health — net sales?
Over 4 years (2021 to 2025), Perrigo Company's digestive health — net sales has grown at a -1.1% compound annual growth rate (CAGR), from $504.3M to $482.8M.
What does digestive health — net sales mean?
This metric represents the total revenue generated from the sale of products within the company's digestive health portfolio, including over-the-counter remedies and related therapeutic solutions. It serves as a key indicator of market demand and brand performance within the gastrointestinal health category. Tracking these sales helps investors assess the segment's contribution to overall top-line growth and its competitive positioning in the consumer healthcare market.

Ask your AI about Perrigo Company's digestive health — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude